Official Title: “A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Active-Controlled Study Evaluating the Efficacy of Vardenafil Versus Tadalafil When Intercourse is Attempted Within 45 Minutes of Administration in Subjects With Erectile Dysfunction”

Evaluating the efficacy of 10mg vardenafil versus 10mg tadalafil in the first 45 minutes post-dosing, in an as-required regimen for 4 weeks in subjects with mild/moderate to severe ED

Study Type: Interventional

Study Design: Treatment, Randomized, Double Blind (Subject, Investigator), Active Control, Parallel Assignment, Safety/Efficacy Study

Intervention(s) in this Clinical Trial

• Drug: Levitra (Vardenafil, BAY38-9456)
  • Vardenafil 10mg, taken orally within 1 hour prior to sexual intercourse
• Drug: Tadalafil
  • Tadalafil 10mg, taken orally within 1 hour prior to sexual intercourse

Arms, Groups and Cohorts in this Clinical Trial

• Experimental: Arm 1
• Active Comparator: Arm 2

Primary Measures

• Sexual Encounter Profile Question 3 (SEP-3)
  • Time Frame: 4 weeks
    Safety Issue?: No

Secondary Measures

• Sexual Encounter Profile Question 2 (SEP-2)
  • Time Frame: 4 weeks
    Safety Issue?: No
• International Index of Erectile Function
  • Time Frame: 4 weeks
    Safety Issue?: No
• Global Confidence Question (GCQ)
  • Time Frame: 4 weeks
    Safety Issue?: No
• Erection Quality Scale (EQS)
  • Time Frame: 4 weeks
    Safety Issue?: No
• General Safety
  • Time Frame: 4 weeks
    Safety Issue?: Yes

Inclusion Criteria:

• Age between 18 and 64 years
• Heterosexual males
• Erectile dysfunction for more than 6 months

Exclusion Criteria:

• Penile anatomical abnormalities
• Spinal cord injury
• History of surgical prostatectomy

Gender Eligibility for this Clinical Trial: Male

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 64 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Sponsor: Bayer

Overall Clinical Trial Officials and Contacts

Bayer Study Director Study Director Bayer  

Information obtained from ClinicalTrials.gov on July 02, 2009

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00663130

Study ID Number: 11333

ClinicalTrials.gov Identifier: NCT00663130

Health Authority: United States: Food and Drug Administration

Click here to find results for studies related to marketed products

Click here and search for drug information provided by the FDA

Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product